Back to top
more

QIAGEN (QGEN)

(Delayed Data from NYSE)

$41.65 USD

41.65
1,406,780

+0.57 (1.39%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $41.61 -0.04 (-0.10%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (75 out of 252)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for QGEN

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for QIAGEN NV falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 1,058 1,418 1,065 729 867
Receivables 382 324 362 440 427
Notes Receivable 0 0 0 0 0
Inventories 398 358 328 291 171
Other Current Assets 310 294 355 207 105
Total Current Assets 2,148 2,394 2,110 1,667 1,570
Net Property & Equipment 765 662 638 559 455
Investments & Advances 3 131 190 379 192
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 73 55 57
Intangibles 3,003 2,897 2,978 3,090 2,773
Deposits & Other Assets 197 203 158 162 188
Total Assets 6,115 6,288 6,147 5,913 5,236
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 84 99 101 118 85
Current Portion Long-Term Debt 588 390 848 43 285
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 407 486 569 346 444
Income Taxes Payable 0 0 0 57 34
Other Current Liabilities 0 0 0 51 103
Total Current Liabilities 1,079 975 1,517 615 951
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 38 39 23
Convertible Debt 0 0 0 0 0
Long-Term Debt 922 1,472 1,094 1,880 1,421
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 306 375 401 580 303
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 2,307 2,821 3,050 3,115 2,699
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 3 3 3 3 3
Capital Surplus 1,915 1,868 1,819 1,834 1,777
Retained Earnings 2,457 2,160 1,792 1,323 1,178
Other Equity -434 -404 -327 -244 -310
Treasury Stock 133 160 190 118 112
Total Shareholder's Equity 3,808 3,467 3,097 2,798 2,537
Total Liabilities & Shareholder's Equity 6,115 6,288 6,147 5,913 5,236
Total Common Equity 3,808 3,467 3,097 2,798 2,537
Shares Outstanding 228.20 220.80 221.10 221.10 220.90
Book Value Per Share 16.69 15.70 14.01 12.65 11.48

Fiscal Year End for QIAGEN NV falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 1,058 1,016 1,332 1,287
Receivables NA 382 327 313 317
Notes Receivable NA 0 0 0 0
Inventories NA 398 399 392 381
Other Current Assets NA 310 221 275 266
Total Current Assets NA 2,148 1,962 2,311 2,251
Net Property & Equipment NA 765 706 707 691
Investments & Advances NA 3 63 98 92
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 3,003 2,977 3,027 3,039
Deposits & Other Assets NA 197 198 205 206
Total Assets NA 6,115 5,907 6,347 6,279
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 84 77 84 84
Current Portion Long-Term Debt NA 588 101 500 393
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 407 347 394 413
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 1,079 524 978 890
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 922 1,382 1,388 1,487
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 306 357 341
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 2,307 2,213 2,724 2,718
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 3 3 3 3
Capital Surplus NA 1,915 1,903 1,890 1,882
Retained Earnings NA 2,457 2,361 2,283 2,215
Other Equity NA -434 -439 -418 -396
Treasury Stock NA 133 134 134 143
Total Shareholder's Equity NA 3,808 3,694 3,624 3,561
Total Liabilities & Shareholder's Equity NA 6,115 5,907 6,347 6,279
Total Common Equity 0 3,808 3,694 3,624 3,561
Shares Outstanding 228.20 228.20 221.10 220.80 220.80
Book Value Per Share 0.00 16.69 16.71 16.41 16.13